Pharmacokinetics (PK) of Human Immunoglobulin 10% Administered Subcutaneously Alone or Following Recombinant Human Hyaluronidase (rHuPH20) in Primary Immunodeficiency Disease (PIDD) Patients

被引：0
|
作者：
Rubinstein, A. [1 ,2 ]
Wasserman, R. L. [3 ]
Melamed, I. [4 ]
Stein, M. [5 ]
McCoy, B. [6 ]
Engl, W. [6 ]
Leibl, H. [6 ]
Gelmont, D. [7 ]
Schiff, R. I. [7 ]
Grossman, W. J. [7 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Montefiore Hosp, Bronx, NY USA
[3] DallasAllergyImmunol, Dallas, TX USA
[4] IMMUNOe, Centennial, CO USA
[5] Allergy Associates Palm Beaches, N Palm Beach, FL USA
[6] Baxter BioSci, Vienna, Austria
[7] Baxter BioSci, Westlake Village, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.848
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB213 / AB213
页数：1
相关论文
共 50 条
  • [21] Recombinant Human Hyaluronidase (rHuPH20) Facilitates Subcutaneous Infusion of Immunoglobulin, Increases Local Fluid Dispersion, and Reduces Induration in a Porcine Model
    Kang, D. W.
    Jadin, L. M.
    Nekoroski, T. A.
    Zepeda, M. L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB85 - AB85
  • [22] Long-Term Efficacy and Safety of Recombinant Human Hyaluronidase (rHuPH20)-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (HyQvia; IGHy) in Patients with Primary Immunodeficiencies (PI)
    Wasserman, Richard L.
    Stein, Mark R.
    Melamed, Isaac
    Kobrynski, Lisa J.
    Gupta, Sudhir
    Puck, Jennifer M.
    Rubinstein, Arye
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB96 - AB96
  • [23] TOLERABILITY AND EFFICACY OF FACILITATED-SUBCUTANEOUS INFUSION OF IMMUNE GLOBULIN (HUMAN), 10% AND RECOMBINANT HUMAN HYALURONIDASE (IGHY) IN PATIENTS (PTS) WITH PRIMARY IMMUNODEFICIENCY DISEASE (PIDD)
    Stein, M.
    Wasserman, R. L.
    Melamed, I.
    Rubinstein, A.
    Engl, W.
    Leibl, H.
    McCoy, B.
    Gelmont, D.
    Schiff, R. I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A95 - A95
  • [24] Patient Preferences for Recombinant Human Hyaluronidase (rHuPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGHy) in Adult Patients with Primary Immunodeficiencies (PI): Phase 3 Study Results
    Ito, Diane
    Ye, Xiaolan
    Xiong, Yan
    Li-McLeod, Josephine
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 376 - 376
  • [25] Contribution of Recombinant Human Hyaluronidase (rHuPH20) in Reducing Infusion Pressures During Subcutaneous Delivery of 10% and 20% IgG in Yucatan Micro-Pigs
    Nekoroski, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB16 - AB16
  • [26] Long Term Safety, Efficacy, and Tolerability of Recombinant Human Hyaluronidase [RHUPH20] -Facilitated Subcutaneous Infusion of Immunoglobulin G (IGG) (HYQVIA; IGHY) in Adults with Primary Immunodeficiencies (PI)
    Wasserman, R. L.
    Stein, M.
    Melamed, I.
    Kobrynski, L.
    Grant, J. A.
    Gupta, S.
    Engl, W.
    Leibl, H.
    Yel, L.
    Schiff, R. I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S310 - S311
  • [27] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Subset of Study Patients With Primary Immunodeficiency Disease (PIDD)
    Wasserman, R. L.
    Melamed, I.
    Stein, M.
    Puck, J.
    Gupta, S.
    Engl, W.
    Leibl, H.
    Gelmont, D.
    Schiff, R. I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB15 - AB15
  • [28] Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (IGHy) in Patients with Primary Immunodeficiency Disease (PIDD): Infections over Time
    Wasserman, Richard L.
    Stein, Mark R.
    Kobrynski, Lisa J.
    Gupta, Sudhir
    Grant, J. Andrew
    Rubinstein, Arye
    Rabbat, Christopher J.
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB219 - AB219
  • [29] Patient Preferences for Recombinant Human Hyaluronidase (RHUPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGHY) in Adults with Primary Immunodeficiencies (PI): Phase 3 Study Results
    Ito, D.
    Ye, X.
    Xiong, Y.
    Li-McLeod, J.
    Schiff, R.
    Faivre, P.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S381 - S382
  • [30] Efficacy Analysis of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
    Schiff, R. I.
    Wasserman, R. L.
    Melamed, I.
    Stein, M.
    Engl, W.
    Leibl, H.
    Gelmont, D.
    Grossman, W. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB15 - AB15
12345